CLINICAL_TRIALS
trial_result
· 2011-11-07
Clinical Trial Update: Autologous and Allogenic Transplantation With Campath-1H for T-Cell Lymphoma [Phase 2]
Summary
A Phase 2 study evaluating autologous and allogeneic transplantation with Campath-1H (alemtuzumab) for T-cell lymphoma was terminated, with results posted in 20…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Lymphoma | Phase 2 | Status: TERMINATED | Results posted: 2011-11-07